Literature DB >> 33501641

Oxysterols and retinal degeneration.

Xun Zhang1, Reem Hasaballah Alhasani1,2, Xinzhi Zhou1, James Reilly1, Zhihong Zeng3, Niall Strang4, Xinhua Shu1,4,5.   

Abstract

Retinal degeneration, characterised by the progressive death of retinal neurons, is the most common cause of visual impairment. Oxysterols are the cholesterol derivatives produced via enzymatic and/or free radical oxidation that regulate cholesterol homeostasis in the retina. Preclinical and clinical studies have suggested a connection between oxysterols and retinal degeneration. Here, we summarise early and recent work related to retina oxysterol-producing enzymes and the distribution of oxysterols in the retina. We examine the impact of loss of oxysterol-producing enzymes on retinal pathology and explore the molecular mechanisms associated with the toxic or protective roles of individual oxysterols in different types of retinal degeneration. We conclude that increased efforts to better understand the oxysterol-associated pathophysiology will help in the development of effective retinal degeneration therapies. LINKED ARTICLES: This article is part of a themed issue on Oxysterols, Lifelong Health and Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.16/issuetoc.
© 2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

Entities:  

Keywords:  cholesterol; oxysterol; retinal degeneration; therapy; toxicity

Year:  2021        PMID: 33501641     DOI: 10.1111/bph.15391

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  1 in total

1.  Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina.

Authors:  Fahad Farhan; Mohammad Almarhoun; Aileen Wong; Amy S Findlay; Chris Bartholomew; Mark T S Williams; Toby W Hurd; Xinhua Shu
Journal:  Cells       Date:  2021-11-07       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.